Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04825587 · ClinicalTrials.gov registry record · NA
The Pediatric ALL Evaluation and Trial
A NA study of ACL Injury and ACL Tear, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT04825587: Recruiting NA study of ACL Injury and ACL Tear, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
NCT04825587 is a NA study of ACL Injury and ACL Tear that is actively recruiting participants, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 240 participants, below the 484-participant average among 12 other ACL Injury trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04825587, a NA study of ACL Injury and ACL Tear, is actively recruiting participants, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall aim of this multicenter RCT is to determine whether concomitant ALL reconstruction in children undergoing and ACL reconstruction will longitudinally result in a lower rate of graft failure than ACL reconstruction alone.
Primary Outcome
To determine whether concomitant ALL reconstruction in children undergoing and ACL reconstruction will longitudinally result in a lower rate of graft failure (confirmed graft re-tear or asymmetric, increased pivot shift) than ACL reconstruction alone.
Conditions Studied
Interventions
- PROCEDURE Patients will be randomized into one of two study arms: (1) concomitant ACL and ALL reconstruction or (2) ACL reconstruction alone.
Study Locations (1)
Illinois
- Lurie Children's Hospital - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2021-04-28 |
| Est. Completion | 2028-04-01 |
| Phase | NA |
What NCT04825587 shows while recruiting
NCT04825587 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 484-participant average among 12 other ACL Injury trials with a reported enrollment target (50% lower).
The record links to 2 conditions, with ACL Injury appearing as the primary indexed condition, and to 1 intervention - of which Patients will be randomized into one of two study arms: (1) concomitant ACL and ALL reconstruction or (2) ACL reconstruction alone. is the first listed.
NCT04825587 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04825587 about?
NCT04825587 is a clinical study titled "The Pediatric ALL Evaluation and Trial". The overall aim of this multicenter RCT is to determine whether concomitant ALL reconstruction in children undergoing and ACL reconstruction will longitudinally result in a lower rate of graft failure than ACL reconstruction alone.
What is the current status of trial NCT04825587?
This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2021-04-28. Estimated completion is 2028-04-01.
What conditions does trial NCT04825587 study?
This clinical trial studies the following conditions: ACL Injury, ACL Tear.
What interventions are being tested in trial NCT04825587?
The interventions under investigation include: Patients will be randomized into one of two study arms: (1) concomitant ACL and ALL reconstruction or (2) ACL reconstruction alone. (PROCEDURE).
Who is sponsoring clinical trial NCT04825587?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04825587 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ACL Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04825587's enrollment target sits among peer trials
240 2nd of 12 the highest of 12 other ACL Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other ACL Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Michigan Split-belt Treadmill Training Program to Improve Long-Term Knee Biomechanics After ACL Reconstruction
RECRUITING · NA
-
Muscle O2 Saturation and Hemoglobin Levels During Rehabilitation From Arthroscopic Surgery
RECRUITING · NA
-
Michigan Split-belt Treadmill Training Program to Improve Acute Knee Biomechanics After ACL Reconstruction
RECRUITING · NA
-
Mindfulness and ACL Surgery
RECRUITING · NA
-
BFR Therapy for Post-Op Rehab of ACL Reconstruction With Quadriceps Tendon Autograft
ACTIVE NOT RECRUITING · NA
-
Comparing Perioperative Education Modalities for ACL Reconstruction on Patient Satisfaction, Self-Efficacy, and Surgical Outcomes
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI